Larsson K and Sollevi A, 1988, Sweden | 5 well subjects with a previous diagnosis of asthma. | Crossover placebo trial | HR | No significant difference | Children only |
| | | BP | No significant difference | Retrospective chart review |
| Increasing doses of adenosine v placebo | | Pulmonary function | No significant difference | |
Losek JD et al, 1999, USA | 82 patients aged 18 yrs or less who received iv adenosine in the ED for the treatment of SVT. | Survey | Successful cardioversion | 72% cardioversion success rate | Dose of adenosine very different to that used clinically |
| | | Adverse effects | 22 adverse patient events, no bronchospasm but 2 complaints of “dyspnoea” in non-asthmatic patients | Subjects well, and in normal sinus rhythm |
| 13 had documented evidence of asthma | | | | |